Francesco Cavazzini

Francesco Cavazzini

Auto-generated profile, based on publicly available information

Francesco Cavazzini

Hematology Section, Azienda Ospedaliero-Universitaria Arcispedale S. Anna, Ferrara, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Leukemia Research Reports
Verified
Journal Article
Open access
MCMaurizio Cavallari
Maurizio Cavallari
MCMaria Ciccone
Maria Ciccone
SFSimonetta Falzoni
Simonetta Falzoni
FCFrancesco Cavazzini
Francesco Cavazzini
LFLuca Formigaro
Luca Formigaro
Antonio CuneoAntonio Cuneo
Antonio Cuneo
Hemophagocytic Lymphohistiocytosis (HLH) is a rare syndrome characterized by ineffective T-cell and NK response. We report the clinical course of a patient with relapsed CLL who developed acute symptoms soon after starting ibrutinib. Hyperpyrexia, splenomegaly, hyperferritinemia, hypertriglyceridemia, cytopenias, and a typical cytokine pattern, i.e. high interleukin (IL)-6, IL10 and IL18, were consistent with a diagnosis of HLH. Coexistent Epstein Barr virus reactivation was documented. Ibrutinib-induced impairment of NK degranulation, associated with EBV reactivation and CLL-related immunodeficiency may have contributed to the development of HLH in our patient.